LD-2 disclosure · 2nd Quarter - Report
INTRA-CELLULAR THERAPIES, INC.
via INTRA-CELLULAR THERAPIES, INC.
Client
- Name
- INTRA-CELLULAR THERAPIES, INC.
- Description
- Biopharmaceutical company
- Location
- New York · United States of America
Registrant
- Firm
- INTRA-CELLULAR THERAPIES, INC.
- Location
- New York, New York, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
P.L. 117-169: Legislation not yet introduced; Negotiation regarding IRA Maximum Fair Price (MFP) and small manufacturer exception; Part D6 protected classes resolution.
LobbyistsANDREW SPERLING
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Health Issues
HR 2630/S. 652: Safe Step Act - provisions regarding protocol for step therapy in pharmacy benefits. S. 1339: Pharmacy Benefit Manager Reform Act - provisions regarding regulation of pharmacy benefit managers.
LobbyistsANDREW SPERLING
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
HR 3938/S. 866: American Innovation and Jobs Act - provisions regarding research and development tax credit amortization.
LobbyistsANDREW SPERLING
TargetedSENATE · HOUSE OF REPRESENTATIVES